3 results
Approved WMOCompleted
To determine the toxicity of adding chloroquine in escalating doses in patients with small cell lung cancer to standard therapy.
Approved WMOCompleted
The study aims to limit the use of anthracyclines and to reduce the dose of ATRA. Another aim is to stratify treatment by risk group: standard risk - WBC <10 x 109/l : high risk - WBC >=10 x 109/l. Furthermore this study aims to…
Approved WMOCompleted
To determine the toxicity of adding chloroquine in escalating doses in patients with small cell lung cancer to standard therapy.